Arcadia Biosciences, Inc. (RKDA)
NASDAQ: RKDA · Real-Time Price · USD
6.15
-0.03 (-0.49%)
Dec 26, 2024, 4:00 PM EST - Market closed
Arcadia Biosciences Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Arcadia Biosciences stock has a target of 6.00, which predicts a decrease of -2.44% from the current stock price of 6.15.
Analyst Consensus: Strong Buy
* Price targets were last updated on Aug 21, 2024.
Analyst Ratings
According to 1 stock analyst, the rating for RKDA is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | -2.44% | Aug 21, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $10 → $6 | Strong Buy | Maintains | $10 → $6 | -2.44% | May 23, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +62.60% | Apr 5, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $15 → $10 | Strong Buy | Maintains | $15 → $10 | +62.60% | Aug 28, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +143.90% | Jul 24, 2023 |
Financial Forecast
Revenue This Year
5.31M
from 5.33M
Decreased by -0.43%
Revenue Next Year
6.66M
from 5.31M
Increased by 25.44%
EPS This Year
-1.43
from -11.30
EPS Next Year
-1.38
from -1.43
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 5.7M | 6.9M | 7.9M |
| Avg | 5.3M | 6.7M | 7.7M |
| Low | 4.9M | 6.4M | 7.4M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 6.5% | 29.7% | 18.3% |
| Avg | -0.4% | 25.4% | 14.9% |
| Low | -8.1% | 20.0% | 10.4% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -1.16 | 0.13 | -2.30 |
| Avg | -1.43 | -1.38 | -2.23 |
| Low | -1.67 | -2.76 | -2.15 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.